Outcome | |||
Parameter | 3 months | 6 months | |
UCVA | Range | 0.2 to 2.0 | 0.1 to 2.0 |
UCVA of 1.0 or better (% of eyes) | 491 eyes (87.5%) | 490 eyes (87.3%) | |
Mean logMAR UCVA ± SD | −0.090 ± 0.118 | −0.089 ± 0.136 | |
aMean decimal visual acuity | 1.23 | 1.23 | |
BSCVA | Range | 0.5 to 2.0 | 0.3 to 2.0 |
BSCVA of 1.0 or better (% of eyes) | 540 eyes (96.2%) | 555 eyes (98.9%) | |
Mean logMAR BSCVA ± SD | −0.131 ± 0.073 | −0.137 ± 0.070 | |
aMean decimal visual acuity | 1.35 | 1.37 | |
Residual SE | Range (D) | +2.25 to –2.00 | +1.25 to −4.125 |
Mean SE ± SD (D) | −0.03 ± 0.34 | −0.12 ± 0.46 | |
Safety index | Mean postoperative BSCVA/mean preoperative BSCVA | 1.35/1.43 (0.94) | 1.37/1.43 (0.96) |
Efficacy index | Mean postoperative UCVA/mean preoperative BSCVA | 1.23/1.43 (0.86) | 1.23/1.43 (0.86) |